Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Interleukin-18 induces insulin resistance in the hyperthyroid state.

Miyauchi S, Matsuura B, Ueda T, Eguchi T, Tamaru M, Yamamoto S, Miyake T, Furukawa S, Abe M, Hiasa Y, Onji M.

Endocr J. 2013;60(4):449-55. Epub 2012 Dec 19.

2.

Increased levels of serum interleukin-18 in Graves' disease.

Miyauchi S, Matsuura B, Onji M.

Thyroid. 2000 Sep;10(9):815-9.

PMID:
11041460
3.

Effect of methimazole treatment for 2 years on circulating IL-4, IgE, TBII, and TSAb in patients with hyperthyroid Graves' disease.

Yamada T, Komiya I, Miyahara Y, Komatsu M, Shima I, Inazawa T, Aizawa T.

Endocr J. 2006 Dec;53(6):783-8. Epub 2006 Sep 19.

4.

Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.

Chu CH, Lee JK, Wang MC, Lu CC, Sun CC, Chuang MJ, Lam HC.

Metabolism. 2008 Oct;57(10):1380-3. doi: 10.1016/j.metabol.2008.05.006.

PMID:
18803942
5.

Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.

Wakelkamp IM, Prummel MF, Wiersinga WM.

Horm Metab Res. 2004 Jan;36(1):44-7.

PMID:
14983406
6.

Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment.

Pedro AB, Romaldini JH, Takei K.

Neuroimmunomodulation. 2011;18(1):45-51. doi: 10.1159/000311519. Epub 2010 Jul 13.

PMID:
20628263
7.

Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.

Corrales JJ, López A, Ciudad J, Mories MT, Miralles JM, Orfao A.

J Endocrinol. 1997 Dec;155(3):491-500.

8.

Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease.

Salvi M, Girasole G, Pedrazzoni M, Passeri M, Giuliani N, Minelli R, Braverman LE, Roti E.

J Clin Endocrinol Metab. 1996 Aug;81(8):2976-9.

PMID:
8768861
9.

Correction of insulin resistance in methimazole-treated patients with Graves disease.

Tene C, Zárate A, Basurto L, Islas S, Revilla C, Ochoa R, Galván R, Santos P.

Rev Invest Clin. 2001 Nov-Dec;53(6):531-5.

PMID:
11921526
10.

[Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].

Bossowski A, Stasiak-Barmuta A, Urban M, Rinderle C.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2004;10(2):93-101. Polish.

PMID:
15504312
12.
13.

Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.

Inukai T, Takanashi K, Takebayashi K, Fujiwara Y, Tayama K, Takemura Y.

Horm Metab Res. 1999 Oct;31(10):576-9.

PMID:
10596968
14.

Elevated serum granulocyte colony-stimulating factor levels in patients with Graves' disease.

Iitaka M, Noh JY, Kitahama S, Fukasawa N, Miura S, Kawakami Y, Kawasaki S, Yamanaka K, Ishii J, Katayama S, Ito K.

Clin Endocrinol (Oxf). 1998 Mar;48(3):275-80.

PMID:
9578815
16.

Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidism.

Jenkins RC, Valcavi R, Zini M, Frasoldati A, Heller SR, Camacho-Hubner C, Gibson JM, Westwood M, Ross RJ.

Clin Endocrinol (Oxf). 2000 Feb;52(2):187-95.

PMID:
10671946
17.

Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease.

Kawakami-Tani T, Fukawa E, Tanaka H, Abe Y, Makino I.

Metabolism. 1997 Oct;46(10):1184-8.

PMID:
9322804
18.

Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.

Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M, Miyamoto T, Arai M, Nagasawa T.

N Engl J Med. 1991 Apr 4;324(14):947-53.

19.

Elevated serum IL-16 and RANTES levels in patients with autoimmune thyroid diseases and modulation by methimazole therapy.

Gu X, Zheng L, Chen X, Ruan L, Zhang H, Ge S, Zhu H, Lin X, Shen F.

Horm Metab Res. 2012 Jun;44(6):482-7. doi: 10.1055/s-0032-1308973. Epub 2012 Apr 2.

PMID:
22473756
20.

Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.

He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW.

Clin Endocrinol (Oxf). 2004 Jun;60(6):676-81.

PMID:
15163329

Supplemental Content

Support Center